Intuitive Surgical ISRG
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Intuitive Surgical (ISRG) Business Model and Operations Summary
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
Key Insights
Intuitive Surgical (ISRG) Core Market Data and Business Metrics
Latest Closing Price
$496.36Market Cap
$177.32 BillionPrice-Earnings Ratio
77.31Total Outstanding Shares
358.28 Million SharesTotal Employees
15,638Dividend
No dividendIPO Date
June 13, 2000SIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
NASDAQHeadquarters
1020 Kifer Road, Sunnyvale, CA, 94086
Historical Stock Splits
If you bought 1 share of ISRG before July 1, 2003, you'd have 4.50 shares today.
| Execution Date | Split Amount |
|---|---|
| October 5, 2021 | 3-for-1 |
| October 6, 2017 | 3-for-1 |
| July 1, 2003 | 1-for-2 (Reverse Split) |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $-706.90 Million |
| Net Cash Flow From Financing Activities, Continuing | $150.90 Million |
| Net Cash Flow From Investing Activities | $-3.27 Billion |
| Net Cash Flow From Operating Activities, Continuing | $2.42 Billion |
| Exchange Gains/Losses | $-800,000 |
| Net Cash Flow | $-707.70 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit, Deferred | $-135.30 Million |
| Cost Of Revenue | $2.72 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Basic Earnings Per Share | $6.54 |
| Basic Average Shares | $355.20 Million |
| Research and Development | $1.15 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $14.20 Million |
| Comprehensive Income/Loss | $2.30 Billion |
| Other Comprehensive Income/Loss Attributable To Noncontrolling Interest | $14.20 Million |
| Other Comprehensive Income/Loss | $-39.80 Million |
| Comprehensive Income/Loss Attributable To Parent | $2.28 Billion |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities | $2.21 Billion |
| Wages | $535.60 Million |
| Inventory | $1.49 Billion |
| Noncurrent Assets | $11.63 Billion |
| Equity Attributable To Noncontrolling Interest | $95.90 Million |
| Fixed Assets | $4.65 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||